Aurobindo Pharma USA Inc. has recalled 1,296 bottles of Famotidine Tablets USP 40mg (famotidine), a prescription medication used to treat heartburn and acid reflux. This recall was initiated because bottles labeled as 40mg tablets were found to contain foreign tablets, specifically Ibuprofen 400mg and Famotidine 20mg. Consuming the incorrect medication could lead to unintended side effects or lack of proper treatment for your condition. These products were distributed in Texas, California, Georgia, and Pennsylvania in 1,000-count bottles.
Taking ibuprofen when expecting famotidine can cause serious health risks, including allergic reactions or stomach bleeding, especially for those with pre-existing conditions or those taking other medications. Additionally, receiving a lower dose of famotidine (20mg instead of 40mg) may result in the ineffective treatment of gastrointestinal conditions.
Consult healthcare provider and return to pharmacy.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.